MACROGENICS INC MGNX

About MACROGENICS INC (MGNX): stock profile, AI score and financials

MACROGENICS INC (MGNX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MGNX at 40.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,092 of 2,925 stocks — the bottom half of the AI-ranked universe. MGNX scores in the top quartile across revenue growth (96.8), institutional flow (86.0). Areas of concern include earnings quality (1.0) and free cash flow (10.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 16.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MACROGENICS INC reports quarterly revenue of $32.8M, net income of $19.5M, an operating margin of -42.2%. MGNX trades on the Nasdaq exchange and files with the SEC under CIK 1125345. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MGNX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MACROGENICS INC directly from SEC EDGAR.

SEC EDGAR: CIK 1125345 →